The angiogenesis process plays a central role not only in the comprehension of breast cancer pathogenesis [29] but also in the development of novel therapeutic strategies, such as monoclonal antibodies targeting the vascular endothelial growth factor (VEGF) [30] and immune checkpoint inhibitor (ICI) drugs [31]. The gene discussed is VEGFA; the disease is breast carcinoma.